Treatment of NTM respiratory infections with inhaled drug delivery

Ended Project Grant Awarded Last action

Award ID
R43AI132067
Recipient
Awarding agency
Obligated
$450,000

Award facts

Assistance listing
93.855 Allergy and Infectious Diseases Research
Completion date
Originally
Place of performance
Loveland, CO, USA

Award details come from USAspending.gov.

Transactions

Action Obligated Date
Amendment $0
Amendment $150,000
Original award $300,000

Quick answers

Who received award R43AI132067?

R43AI132067 was awarded to Aerophase, Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on February 6, 2017.

How much is award R43AI132067 worth?

$450,000 has been obligated on R43AI132067.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award